With President Trump’s signing of HR 7148, experts are now racing to get a grasp on the monumental shifts in pharmacy that will stem from this new legislation.
Jesse Dresser, Esq
Advertisement
Jesse Dresser, Esq, partner in the Life Sciences Department and head of the Pharmacy Practice Group at Frier Levitt Attorneys at Law
Articles by Jesse Dresser, Esq
As lawmakers continue to deliberate on HR 7148, pharmacy law expert, Jesse Dresser, Esq, joined Drug Topics to discuss its provisions related to PBMs.
If signed by President Trump in time to avoid a government shutdown, HR 7148 has potential to enforce significant change in the prescription drug supply chain.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Bipartisan Legislation Aims to Address Consolidation and Vertical Integration of PBMs
2
FDA Removes Black Box Warning on 6 Menopausal Hormone Therapy Products
3
The Evolution of DTP Pharmacy Models and the Future of Digital Health
4
Cigna to Remedy Years of Unfair Business Practices with Patients and Pharmacies
5